Citadel Advisors’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-20,600
Closed -$627K 13675
2025
Q3
$627K Buy
+20,600
New +$633K ﹤0.01% 8584
2025
Q2
Sell
-9,600
Closed -$336K 14339
2025
Q1
$336K Buy
9,600
+2,800
+41% +$111K ﹤0.01% 9330
2024
Q4
$303K Sell
6,800
-6,200
-48% -$278K ﹤0.01% 9641
2024
Q3
$567K Buy
13,000
+3,700
+40% +$139K ﹤0.01% 7990
2024
Q2
$252K Buy
9,300
+4,900
+111% +$142K ﹤0.01% 9482
2024
Q1
$129K Sell
4,400
-5,400
-55% -$164K ﹤0.01% 11002
2023
Q4
$369K Sell
9,800
-5,900
-38% -$217K ﹤0.01% 8732
2023
Q3
$707K Buy
15,700
+6,700
+74% +$406K ﹤0.01% 7316
2023
Q2
$663K Sell
9,000
-13,300
-60% -$897K ﹤0.01% 7312
2023
Q1
$1.31M Buy
22,300
+14,400
+182% +$794K ﹤0.01% 6220
2022
Q4
$398K Buy
7,900
+5,400
+216% +$324K ﹤0.01% 8725
2022
Q3
$218K Sell
2,500
-4,100
-62% -$431K ﹤0.01% 10241
2022
Q2
$751K Sell
6,600
-1,200
-15% -$138K ﹤0.01% 7689
2022
Q1
$1.01M Sell
7,800
-33,500
-81% -$4.83M ﹤0.01% 7671
2021
Q4
$7.45M Buy
41,300
+30,100
+269% +$5.22M ﹤0.01% 3599
2021
Q3
$1.66M Sell
11,200
-3,700
-25% -$567K ﹤0.01% 6835
2021
Q2
$2.26M Buy
14,900
+1,300
+10% +$181K ﹤0.01% 6291
2021
Q1
$1.77M Buy
13,600
+10,800
+386% +$1.39M ﹤0.01% 6705
2020
Q4
$336K Sell
2,800
-21,400
-88% -$2.1M ﹤0.01% 8874
2020
Q3
$1.81M Buy
24,200
+19,500
+415% +$1.35M ﹤0.01% 4906
2020
Q2
$332K Buy
+4,700
New +$322K ﹤0.01% 7755
2019
Q4
Sell
-5,100
Closed -$369K 9552
2019
Q3
$369K Buy
5,100
+1,400
+38% +$103K ﹤0.01% 7251
2019
Q2
$318K Buy
3,700
+900
+32% +$73.1K ﹤0.01% 7496
2019
Q1
$226K Sell
2,800
-8,100
-74% -$606K ﹤0.01% 8041
2018
Q4
$668K Buy
10,900
+7,500
+221% +$508K ﹤0.01% 5950
2018
Q3
$244K Sell
3,400
-2,200
-39% -$139K ﹤0.01% 7914
2018
Q2
$294K Sell
5,600
-1,400
-20% -$65.8K ﹤0.01% 7244
2018
Q1
$304K Buy
7,000
+1,700
+32% +$78.2K ﹤0.01% 6728
2017
Q4
$257K Buy
+5,300
New +$267K ﹤0.01% 6698
2016
Q1
Sell
-6,200
Closed -$193K 7617
2015
Q4
$193K Sell
6,200
-2,100
-25% -$62K ﹤0.01% 5851
2015
Q3
$258K Buy
8,300
+2,200
+36% +$78.8K ﹤0.01% 5785
2015
Q2
$230K Buy
6,100
+3,700
+154% +$135K ﹤0.01% 6133
2015
Q1
$84K Buy
+2,400
New +$79.1K ﹤0.01% 6986
2014
Q1
Sell
-2,000
Closed -$51K 7966
2013
Q4
$51K Sell
2,000
-3,400
-63% -$81.2K ﹤0.01% 6022
2013
Q3
$128K Buy
5,400
+5,100
+1,700% +$114K ﹤0.01% 5162
2013
Q2
$6K Buy
+300
New +$5.54K ﹤0.01% 6327

Other funds holding OMCL

Citadel Advisors's OMCL Position: Q1 2026 in Review

Citadel Advisors sold out of Omnicell (OMCL) in Q1 2026, closing a stake of 252,062 shares — an estimated $11.4M sold.

Citadel Advisors first reported a position in OMCL in Q2 2013 and held it in 39 quarters. The position peaked at $30.2M in Q3 2022. 272 funds tracked by Wall St. Rank hold OMCL as of Q1 2026.

  • Citadel Advisors reported no remaining Omnicell position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 252,062 Omnicell shares in Q1 2026, an estimated $11.4M.
  • Citadel Advisors first reported a position in Omnicell in Q2 2013 and held it in 39 quarters.
  • Citadel Advisors's Omnicell position peaked at $30.2M in Q3 2022.
  • 272 funds tracked by Wall St. Rank held Omnicell as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.